Riskpilot← Back to searchSign inGet full accessSTIFTELSEN NORDIC CLINIC
STIActiveOrg 998547202Torvmyrveien 26, 4070 RandabergGeneral medical practice activities · NACE 8621Est. 20120 employees
Revenue 2024
NOK 851K
-79% vs 2023
EBITDA margin
-30.8%
-107% vs 2023
Equity ratio
99.9%
Financial strength
Net profit 2024
NOK -81K
-102% vs 2023
| Revenue | NOK 851K | -79% |
| EBITDA | NOK -263K | -107% |
| Net profit | NOK -81K | -102% |
| Total assets | NOK 42,4M | -7% |
| Equity | NOK 42,3M | +0% |
| Employees | 0 | — |
Legal name
STIFTELSEN NORDIC CLINIC
Org number
998547202
Legal form
Stiftelse
NACE code
8621 · General medical practice activities
Founded
4. september 2012
Share capital
NOK 200 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Å investere i virksomhet som driver helsetjenester og utdanning innen helsefaglig disipliner i etiopia og/eller andre land i afrika, og det som står i naturlig forbindelse med dette.
Address
Torvmyrveien 26, 4070 Randaberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 194 | 15 617 | 100 | 4 126 | 851 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 159 | 15 580 | 37 | 4 030 | −263 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 159 | 15 580 | 37 | 4 030 | −263 |
| Net financials | −66 | −88 | −55 | −161 | 181 |
| Profit before tax | 94 | 15 493 | −18 | 3 869 | −81 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 94 | 15 493 | −18 | 3 869 | −81 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 46 023 | 46 809 | 43 317 | 45 398 | 42 362 |
| Equity | 23 073 | 38 566 | 38 548 | 42 417 | 42 336 |
| Long-term debt | 19 378 | 0 | 4 751 | 2 955 | 0 |
| Short-term debt | 3 571 | 8 244 | 18 | 26 | 25 |
| Total debt | 22 950 | 8 244 | 4 769 | 2 981 | 25 |
EBITDA margin
-30.8%
This company
15.8%
Market median
-295% vs market
20202024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
20202024
Net profit margin
-9.6%
This company
8.1%
Market median
-219% vs market
20202024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
STIFTELSEN NORDIC CLINIC 
NORDIC CLINIC ASBoard members of STIFTELSEN NORDIC CLINIC also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Vistnes | Chairman | 0 companies |
| Lars Arild Tolo | Board of Directors | 0 companies |
| Ingveig Tveranger | Board of Directors | 0 companies |
| Hans Petter Torvik | Board of Directors | 0 companies |
| Audun Veggeland | Board of Directors | 0 companies |